Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment

Specific prophylactic migraine treatments are urgently needed because of the unmet needs of many migraine patients. Antibodies targeting calcitonin gene-related peptide (CGRP) or its receptor have recently shown efficacy in episodic and chronic migraine and will be available soon.

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Genome Med
Asıl Yazarlar: MaassenVanDenBrink, Antoinette, Terwindt, Gisela M., van den Maagdenberg, Arn M. J. M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2018
Konular:
Comment
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5824555/
https://ncbi.nlm.nih.gov/pubmed/29471874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-018-0524-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller